REG - GSK PLC - Director/PDMR Shareholding

GSKAnnouncement

13/02/2024 15:45

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240213:nRSM0179Da&default-theme=true

RNS Number : 0179D  GSK PLC  13 February 2024

GSK plc (the 'Company')

Vesting of Conditional Share Awards under the Share Value Plan and Sale of
Ordinary Shares and American Depositary Shares

This notification sets out the vesting details for Person Discharging
Managerial Responsibilities ('PDMRs') of Conditional Share Awards over
Ordinary Shares and American Depositary Shares ('ADSs') made in 2021 under the
GlaxoSmithKline Share Value Plan and the subsequent sale of Ordinary Shares
and ADSs to meet tax liabilities. The awards, which were conditional on
continued employment with the GSK group, vested on 12 February 2024.

Transaction notification

 1.  Details of PDMR/person closely associated with them ('PCA')
 a)  Name                                     Shobie Ramakrishnan
 b)  Position/status                          Chief Digital and Technology Officer
 c)  Initial notification/                    Initial notification

     amendment
 2.  Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name                                     GSK plc
 b)  LEI                                      5493000HZTVUYLO1D793
 3.  Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transaction(s) has been conducted
 a)  Description of the financial instrument  American Depositary Shares ('ADSs')

                                              ISIN: US37733W2044
 b)  Nature of the transaction                The vesting of ADS awarded in 2021 under the Company's Share Value Plan
 c)  Price(s) and volume(s)                                       Price(s)            Volume(s)
                                                                  $41.0648            5,740

                                                                  .

 d)  Aggregated information                   N/A (single transaction)

     Aggregated volume Price
 e)  Date of the transaction                  2024-02-12
 f)  Place of the transaction                 N/A

 

 1.  Details of PDMR/person closely associated with them ('PCA')
 a)  Name                                     Shobie Ramakrishnan
 b)  Position/status                          Chief Digital and Technology Officer
 c)  Initial notification/                    Initial notification

     amendment
 2.  Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name                                     GSK plc
 b)  LEI                                      5493000HZTVUYLO1D793
 3.  Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transaction(s) has been conducted
 a)  Description of the financial instrument  American Depositary Shares ('ADSs')

                                              ISIN: US37733W2044
 b)  Nature of the transaction                The sale of ADS to meet tax liabilities on the vesting of awards granted in
                                              2021 under the Company's Share Value Plan
 c)  Price(s) and volume(s)                                        Price(s)             Volume(s)
                                                                   $41.0648             3,086

                                                                   .

                                                                   .

 d)  Aggregated information                   N/A (single transaction)

     Aggregated volume Price
 e)  Date of the transaction                  2024-02-12
 f)  Place of the transaction                 New York Stock Exchange (XNYS)

 

 1.  Details of PDMR/person closely associated with them ('PCA')
 a)  Name                                     Tony Wood
 b)  Position/status                          Chief Scientific Officer
 c)  Initial notification/                    Initial notification

     amendment
 2.  Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name                                     GSK plc
 b)  LEI                                      5493000HZTVUYLO1D793
 3.  Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transaction(s) has been conducted
 a)  Description of the financial instrument  Ordinary shares of 31 ¼ pence each ('Ordinary Shares')

                                              ISIN: GB00BN7SWP63
 b)  Nature of the transaction                The vesting of Ordinary Shares awarded in 2021 under the Company's Share Value
                                              Plan
 c)  Price(s) and volume(s)                                         Price(s)              Volume(s)
                                                                    £16.4141              10,947

 d)  Aggregated information                   N/A (single transaction)

     Aggregated volume Price
 e)  Date of the transaction                  2024-02-12
 f)  Place of the transaction                 N/A

 1.  Details of PDMR/person closely associated with them ('PCA')
 a)  Name                                     Tony Wood
 b)  Position/status                          Chief Scientific Officer
 c)  Initial notification/                    Initial notification

     amendment
 2.  Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name                                     GSK plc
 b)  LEI                                      5493000HZTVUYLO1D793
 3.  Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transaction(s) has been conducted
 a)  Description of the financial instrument  Ordinary shares of 31 ¼ pence each ('Ordinary Shares')

                                              ISIN: GB00BN7SWP63
 b)  Nature of the transaction                The sale of Ordinary Shares to meet tax liabilities on the vesting of awards
                                              granted in 2021 under the Company's Share Value Plan
 c)  Price(s) and volume(s)                                         Price(s)              Volume(s)
                                                                    £16.4141              5,146

                                                                    .

 d)  Aggregated information                   N/A (single transaction)

     Aggregated volume Price
 e)  Date of the transaction                  2024-02-12
 f)  Place of the transaction                 London Stock Exchange (XLON)

 1.  Details of PDMR/person closely associated with them ('PCA')
 a)  Name                                     Victoria Whyte
 b)  Position/status                          Company Secretary
 c)  Initial notification/                    Initial notification

     amendment
 2.  Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name                                     GSK plc
 b)  LEI                                      5493000HZTVUYLO1D793
 3.  Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transaction(s) has been conducted
 a)  Description of the financial instrument  Ordinary shares of 31 ¼ pence each ('Ordinary Shares')

                                              ISIN: GB00BN7SWP63
 b)  Nature of the transaction                The vesting of Ordinary Shares awarded in 2021 under the Company's Share Value
                                              Plan
 c)  Price(s) and volume(s)                                         Price(s)              Volume(s)
                                                                    £16.4141              10,050

 d)  Aggregated information                   N/A (single transaction)

     Aggregated volume Price
 e)  Date of the transaction                  2024-02-12
 f)  Place of the transaction                 N/A

 

 1.  Details of PDMR/person closely associated with them ('PCA')
 a)  Name                                     Victoria Whyte
 b)  Position/status                          Company Secretary
 c)  Initial notification/                    Initial notification

     amendment
 2.  Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name                                     GSK plc
 b)  LEI                                      5493000HZTVUYLO1D793
 3.  Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transaction(s) has been conducted
 a)  Description of the financial instrument  Ordinary shares of 31 ¼ pence each ('Ordinary Shares')

                                              ISIN: GB00BN7SWP63
 b)  Nature of the transaction                The sale of Ordinary Shares to meet tax liabilities on the vesting of awards
                                              granted in 2021 under the Company's Share Value Plan
 c)  Price(s) and volume(s)                                         Price(s)              Volume(s)
                                                                    £16.4141              4,724

                                                                    .

 d)  Aggregated information                   N/A (single transaction)

     Aggregated volume Price
 e)  Date of the transaction                  2024-02-12
 f)  Place of the transaction                 London Stock Exchange (XLON)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHSFIFIDELSEDE